Mutations in SOD1 have been implicated in ALS since 1993, and mutant SOD1 mice and in vitro models have been the dominant models employed to investigate pathogenesis and potential therapies for ALS (Rosen et al., 1993). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.